Rigel Pharmaceuticals (RIGL) PT Raised to $11 at H.C. Wainwright

February 18, 2021 11:06 AM EST Send to a Friend
H.C. Wainwright analyst Joseph Pantginis raised the price target on Rigel Pharmaceuticals (NASDAQ: RIGL) to $11.00 (from $8.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login